Inaugural summit to explore artificial intelligence

A new virtual conference will explore how artificial intelligence (AI) can help health care providers and scientists efficiently analyze vast amounts of data and make more informed decisions, the Endocrine Society announced today.

Moderate coffee and caffeine consumption is associated with lower risk of developing multiple cardiometabolic diseases, new study finds

Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease and stroke, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Eating Patterns and the Neural Respiratory Clock Coordinate Daily Rhythms of Breathing

Article title: Time-restricted feeding reveals a role for neural respiratory clocks in optimizing daily ventilatory-metabolic coupling in mice. Authors: Aaron A. Jones, Gabriella M. Marino, Deanna M. Arble From the authors: “We find that central circadian timing synergizes with metabolism to optimize…

Cedars-Sinai Again Ranked in Top Tier of U.S. Hospitals

Cedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024-25” rankings.

UT Southwestern once again ranked best hospital in DFW

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth for the eighth consecutive year and ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas, according to U.S. News & World Report’s annual Best Hospitals list released today.

Endocrine Society urges passage of the Right to IVF Act

The Endocrine Society endorses the Right to IVF Act, which was introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA) and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF), and urges the Senate to pass the Right to IVF Act on June 12th to ensure that the freedom to start and grow a family is protected and accessible to everyone in the United States.

Type of weight loss surgery women undergo before pregnancy may influence children’s weight gain

The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease

Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Metformin may be as safe as insulin during pregnancy, 11-year data shows

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. This is the first study to look at longer term effects of metformin use during pregnancy.

Persons of nonbinary gender may desire lower-dose testosterone treatment than guidelines recommend

Among transgender and gender-diverse adults whose gender identity is nonbinary—not exclusively male or female—and who choose low-dose hormone treatment, most prefer to continue testosterone therapy at lower-than-recommended doses after at least six months of treatment, a new study finds. The study will be presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions

Most patients with thyroid eye disease treated with teprotumumab didn’t require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass., and published in the journal Thyroid.

Study finds potentially treatable factors to improve symptoms in men stopping illicit steroids

Men who illicitly used steroids to boost muscle size and physical performance and have stopped in the past year have impaired sexual function compared with men currently using steroids, according to a study being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Hot flashes in menopausal women may signal increased risk for heart and metabolic issues

Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Almost 20% of breast cancer survivors may experience excess weight gain

Almost one out of five breast cancer survivors may experience weight gain of more than 10%, suggests a study presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. A number of factors are associated with excessive weight gain, the researchers found.

People with well-controlled, long-duration type 1 diabetes may still face high risk of heart disease

People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Anti-obesity medication tirzepatide remains effective even for those with diabetes and other complications

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Asian patients more likely to develop type 2 diabetes 1 year after prediabetes diagnosis compared to white and Black patients

One year after a prediabetes diagnosis, Asians were more likely to develop diabetes mellitus whereas Black patients were more likely to remain in prediabetes range, highlighting racial disparities in diabetes prevention, according to data presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Childhood sedentariness may cause premature liver damage in young adulthood

Children who are sedentary for more than six waking hours a day have a significantly increased risk of severe fatty liver disease and liver cirrhosis by young adulthood, a new study finds. The research findings will be presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass and published in Nature’s npj Gut and Liver.

Childhood stress linked with earlier substance use in male and female teens

Stress during childhood is associated with earlier substance use in male and female adolescents, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. Traumatic events may increase substance use risk for males, while environmental stress and early puberty may increase the risk for females, the researchers found.

ENDO 2024 press conferences to highlight male birth control, anti-obesity medications

Researchers will delve into emerging research in diabetes, obesity, reproductive health and other aspects of hormone health during the Endocrine Society’s ENDO 2024 news conferences June 1-4.

Lily Ng and Douglas Forrest of NIDDK win Endocrine Society’s 2024 Endocrine Images Art Competition

The Endocrine Society is delighted to announce that Lily Ng, PhD, and Douglas Forrest, Ph.D., have won the Society’s 2024 Endocrine Images Art Competition for their image of the astrocyte cell that expresses type 2 deiodinase.

علاج عُقيدات الغدة الدرقية بدون جراحة

مدينة روتشستر، ولاية مينيسوتا – معظم التكتلات أو العُقيدات في الغدة الدرقية، التي هي غدة في عنقك، غير ضارة ولا تحتاج إلى علاج. ولكنها في بعض الأحيان قد تصبح أكبر وتسبب مشكلات مثل عُسر البلع. في هذه الحالات قد يحتاج الأطباء إلى إجراء جراحة لإزالتها. 

Nerve decompression shows promise for diabetic neuropathy patients

Surgical nerve decompression, used to treat conditions such as carpal tunnel syndrome and sciatica, could play a role in relieving the pain of diabetic neuropathy patients, researchers at UT Southwestern Medical Center found.